ChinaDaily Briefs

China: Jinko Solar, Alibaba Group, Suchuang Gas Corp, Pag, ABM Investama, Betters Medical Investment Holdings, Gajah Tunggal and more

In today’s briefing:

  • STAR50 Index Rebalance Preview: 3 Changes or 5? It Depends…
  • Alibaba: May Be a Good Time to Double Down On Shorts With 4QFY22 Set For Another Disappointment
  • Suchuang Gas’ Scheme Meeting on 10 June Is a Welcome Exit from the Ongoing Share Suspension
  • PAG Pre-IPO – The Negatives – Planned Reorg Don’t Sound Great
  • Asia HY Monthly – Oil & Gas Update Following Russia’S Invasion Of Ukraine – Lucror Analytics
  • Pre-IPO Betters Medical Investment Holdings – The Industry, the Business and the Concerns
  • Morning Views Asia: Gajah Tunggal, Times China

STAR50 Index Rebalance Preview: 3 Changes or 5? It Depends…

By Brian Freitas


Alibaba: May Be a Good Time to Double Down On Shorts With 4QFY22 Set For Another Disappointment

By Oshadhi Kumarasiri

  • Alibaba Group (9988 HK)’s fourth-quarter results will be out soon and we predict another disappointing quarter with mid-single-digit revenue growth.
  • The company’s FY23 revenue guidance could be significantly weaker than the current consensus estimate as rumoured layoffs and budget cuts are likely to affect Alibaba Group (BABA US)’s growth.
  • With the share price near the upper end of the trend channel leading up to 4QFY22 earnings, we think it’s a good time to add to existing short positions.

Suchuang Gas’ Scheme Meeting on 10 June Is a Welcome Exit from the Ongoing Share Suspension

By Arun George

  • The scheme document is out with the Court meeting scheduled for 10 June. The IFA considers the offer to be fair and reasonable. Suchuang Gas Corp (1430 HK) remains suspended.
  • Key conditions are the headcount test and approval by at least 75% of disinterested shareholders (<10% of all disinterested shareholders rejection). 
  • Excluding the irrecovables, no shareholder holds a blocking stake. As the timeframe to fulfil the resumption guidance remains highly uncertain, the offer is a welcome exit opportunity. 

PAG Pre-IPO – The Negatives – Planned Reorg Don’t Sound Great

By Sumeet Singh

  • PAG aims to raise around US$2bn via its Hong Kong IPO.
  • PAG is an alternative investment firm focused on Asia-Pacific (APAC), it had approximately US$50bn in assets under management (AUM), as of Dec 21.
  • In this note, we will talk about the not so positive aspects of the deal.

Asia HY Monthly – Oil & Gas Update Following Russia’S Invasion Of Ukraine – Lucror Analytics

By Charles Macgregor

This month, we provide an update on the developments in the Oil & Gas sector following Russia’s invasion of Ukraine.

The Asia Monthly focuses on providing updates on recent events, information on new issues and spread movements, as well as summarising our top picks, and discussing specific areas of interest in the “In-Focus” section. The Asia Monthly is intended to broaden investors’ understanding of the Asian USD high-yield market.


Pre-IPO Betters Medical Investment Holdings – The Industry, the Business and the Concerns

By Xinyao (Criss) Wang

  • The MWA market that Betters belongs to has showed rapid growth and large potential. Obviously, Betters would benefit from it based on its existing products and leading market position.
  • However, the medical device industry in China is subject to strict policy supervision. It cannot rule out the possibility that the Company’s products would be included in the centralized procurement.
  • In terms of valuation, Micro-Tech Nanjing Co Ltd (688029 CH) could be a comparable company,  but Betters’ valuation should be lower than it.

Morning Views Asia: Gajah Tunggal, Times China

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Before it’s here, it’s on Smartkarma